GRIN2B and schizophrenia: Gaining an understanding of the overlap in the NMDAR populations and circuitry impacted by ketamine and GluN2B NAMs may provide insight into the core mechanisms resulting in the antidepressant response as well as the cognitive disruption and psychotomimetic effects relevant to the NMDAR hypofunction hypothesis of schizophrenia.